Acurx Pharmaceuticals Receives New Patent

Acurx Pharmaceuticals has been granted a new patent by the Korean Patent Office for its innovative DNA Polymerase IIIC inhibitors. This development marks a significant step for the late-stage biopharmaceutical company as it continues to advance its novel class of small molecule drugs. The patent protection is expected to bolster the company's intellectual property portfolio and support its ongoing research and development efforts in creating new therapeutic solutions.